NCT07014787

Brief Summary

The aim of this study is to investigate the effect of grades of chondromalacia on static and dynamic balance.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 5, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2025

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

June 3, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 11, 2025

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2025

Completed
Last Updated

June 11, 2025

Status Verified

June 1, 2025

Enrollment Period

7 months

First QC Date

June 3, 2025

Last Update Submit

June 3, 2025

Conditions

Keywords

Biodex balance system static and dynamic balance assessment of chondromalacia

Outcome Measures

Primary Outcomes (1)

  • Measuring static and dynamic balance

    Measuring static and dynamic balance using biodex balance system

    up to four weeks

Study Arms (5)

Control Group

Control group of 20 healthy patients Normal MRI Study

grade I chondromalacia.

Experimental group of 20 patients with grade I chondromalacia Softening and swelling, intact surface Nearly normal (soft indentation and/or superficial fissures and cracks) Increased T2 signal intensity of morphologically normal cartilage

grade II chondromalacia

Experimental group of 20 patients with grade II chondromalacia. Fragmentation and fissuring of articular cartilage affecting an area of less than 0.5 inches Abnormal (lesions extending to \<50% of cartilage depth) A: Superficial partial-thickness cartilage defect \<50% of total articular surface thickness B: Deep partial-thickness cartilage defect \>50% of total articular surface thickness

grade III chondromalacia

Experimental group of 20 patients with grade III chondromalacia Fragmentation and fissuring of articular cartilage affecting an area greater than 0.5 inches Severely abnormal (lesions extending \>50% of cartilage depth, but not through subchondral bone) Full-thickness cartilage defect

grade IV chondromalacia

Experimental group of 20 patients with grade IV chondromalacia Cartilage erosion to bone Lesions involving subchondral bone

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

100 patients, 80 with different grades of chondromalacia (Grade I, II, III, IV) with 20 participants in each group and 20 healthy participants in the control group will be recruited for the study.

You may qualify if:

  • Age ranged from 18 to 40 years old
  • groups include both males and females
  • Patients with Grade I, II, III and IV chondromalacia: Confirmation of diagnosis by MRI
  • BMI will be ranged from 19.0 to 29.0
  • Patients with Unilateral or bilateral chondromalacia.
  • Chronic cases for more than 3 months.
  • Positive sign of Knee pain according to patellar Grind Test

You may not qualify if:

  • patients have not undergone knee replacement.
  • patients have not done Intra-articular injection in the affected knee for the past 3 months.
  • Patients with rheumatoid arthritis or other inflammatory arthritis.
  • Patients with Vestibular disorders or neurological conditions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of physical therapy Cairo University

Giza, 12518, Egypt

RECRUITING

MeSH Terms

Conditions

Chondromalacia Patellae

Condition Hierarchy (Ancestors)

Cartilage DiseasesMusculoskeletal DiseasesConnective Tissue DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Selwan Khaled Ayad, Teacher Assistant

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Selwan Khaled Ayad, teacher Assistant

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Teaching Assistant

Study Record Dates

First Submitted

June 3, 2025

First Posted

June 11, 2025

Study Start

November 5, 2024

Primary Completion

May 30, 2025

Study Completion

June 15, 2025

Last Updated

June 11, 2025

Record last verified: 2025-06

Locations